**3. Conclusion**

The need for appropriate immuno-prophylaxis or immunotherapy against candidiasis is readily apparent. Therefore, the relationship between killed *Candida albicans* and the hosts' white blood cells in terms of recognition and response clearly suggest an interesting immunoprotection against viable *C. albicans.*

A safe and effective therapeutic alternatives to combat these infections and to eliminate potential problems of toxicity and emergence of resistance to the limited options of antifungal drugs is needed [32]. Therefore, killed *C. albicans* is an immune-based prophylactic and therapeutic approach [33] which represents novel option against *C. albicans* infections [32].

### **Thanks**

I want to specially thank my brother, Muhammad I. Odaki for his tremendous support.
